Propofol: An immunomodulating agent

被引：101

作者：

Marik, PE ^{[1
]}

机构：

[1] Thomas Jefferson Univ, Div Pulm & Crit Care Med, Philadelphia, PA 19107 USA

来源：

PHARMACOTHERAPY | 2005年 / 25卷 / 05期

关键词：

propofol; ethylenediaminetetraacetic acid; metabisulfite; EDTA; cytokines; nuclear factor-kappa B; nitric oxide; lipid peroxidation; antioxidant;

D O I：

10.1592/phco.2005.25.5_Part_2.28S

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Propofol (2,6-diisopropylphenol) is a potent intravenous hypnotic agent widely administered for induction and maintenance of anesthesia and for sedation in the intensive care unit. Propofol is insoluble in water and therefore is formulated in a lipid emulsion. In addition, a preservative (ethylenediaminetetraacetic acid [EDTA] or sodium metabisulfite) is added to retard bacterial growth. Propofol has antiinflammatory properties, decreasing production of proinflammatory cytokines, altering expression of nitric oxide, and inhibiting neutrophil function. Propofol also is a potent antioxidant. The added preservatives have biologic activity; EDTA has antiinflammatory properties, whereas metabisulfite may cause lipid peroxidation. The antiinflammatory and antioxidant properties of propofol may have beneficial effects in patients with sepsis and systemic inflammatory response syndrome.

引用

页码：28S / 33S

页数：6

共 87 条

[1] PROPOFOL REDUCES NEURONAL TRANSMISSION DAMAGE AND ATTENUATES THE CHANGES IN CALCIUM, POTASSIUM, AND SODIUM DURING HYPERTHERMIC ANOXIA IN THE RAT HIPPOCAMPAL SLICE [J].

AMORIM, P ;

CHAMBERS, G ;

COTTRELL, J ;

KASS, IS .

ANESTHESIOLOGY, 1995, 83 (06) :1254-1265

[2] Compartmentalised inducible nitric-oxide synthase activity in septic shock [J].

Annane, D ;

Sanquer, S ;

Sébille, V ;

Faye, A ;

Djuranovic, D ;

Raphaël, JC ;

Gajdos, P ;

Bellissant, E .

LANCET, 2000, 355 (9210) :1143-1148

[3] Role of lipid in sulfite-dependent propofol dimerization [J].

Baker, MT ;

Gregerson, MS ;

Naguib, M .

ANESTHESIOLOGY, 2004, 100 (05) :1235-1241

[4] Free radical and drug oxidation products in an intensive care unit sedative: Propofol with sulfite [J].

Baker, MT ;

Gregerson, MS ;

Martin, SM ;

Buettner, GR .

CRITICAL CARE MEDICINE, 2003, 31 (03) :787-792

[5] Sulfite supported lipid peroxidation in propofol emulsions [J].

Baker, MT ;

Dehring, DJ ;

Gregerson, MS .

ANESTHESIOLOGY, 2002, 97 (05) :1162-1167

[6] Propofol (diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock [J].

Basu, S ;

Mutschler, DK ;

Larsson, AO ;

Kiiski, R ;

Nordgren, A ;

Eriksson, MB .

RESUSCITATION, 2001, 50 (03) :341-348

[7] Tumor necrosis factor-α converting enzyme [J].

Black, RA .

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (01) :1-5

[8]

Brock J H, 1999, Curr Opin Clin Nutr Metab Care, V2, P507

[9] Propofol reduces nitric oxide biosynthesis in lipopolysaccharide-activated macrophages by downregulating the expression of inducible nitric oxide synthase [J].

Chen, RM ;

Wu, GJ ;

Tai, YT ;

Sun, WZ ;

Lin, YL ;

Jean, WC ;

Chen, TL .

ARCHIVES OF TOXICOLOGY, 2003, 77 (07) :418-423

[10] PROPOFOL INDUCES BRONCHODILATION IN A PATIENT MECHANICALLY VENTILATED FOR STATUS-ASTHMATICUS [J].

CONTI, G ;

FERRETTI, A ;

TELLAN, G ;

ROCCO, M ;

LAPPA, A .

INTENSIVE CARE MEDICINE, 1993, 19 (05) :305-305

← 1 2 3 4 5 6 7 8 9 →